ERIC THOMAS SCHMIDT - 16 Dec 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Eric Schmidt
Issuer symbol
RLMD
Transactions as of
16 Dec 2022
Net transactions value
$0
Form type
4
Filing time
20 Dec 2022, 16:33:28 UTC
Previous filing
17 Jun 2022
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +57,042 $0.000000 57,042 16 Dec 2022 Common Stock 57,042 $3.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 16 equal quarterly installments commencing on March 16, 2023.